200 related articles for article (PubMed ID: 8976095)
1. [Purine nucleoside phosphorylase (PNP)].
Sakiyama T
Nihon Rinsho; 1996 Dec; 54(12):3220-5. PubMed ID: 8976095
[TBL] [Abstract][Full Text] [Related]
2. Purine nucleoside phosphorylase inhibition as a novel therapeutic approach for B-cell lymphoid malignancies.
Furman RR; Hoelzer D
Semin Oncol; 2007 Dec; 34(6 Suppl 5):S29-34. PubMed ID: 18086344
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of purine-nucleoside phosphorylase deficiency.
Albert D; Bluestein HG; Willis RC; Nette K; Seegmiller JE
Cell Immunol; 1984 Jul; 86(2):501-9. PubMed ID: 6428752
[TBL] [Abstract][Full Text] [Related]
4. [Purine nucleoside phosphorylase (PNP)].
Taniguchi A
Nihon Rinsho; 2003 Jan; 61 Suppl 1():85-90. PubMed ID: 12629696
[No Abstract] [Full Text] [Related]
5. [PNP (purine nucleoside phosphorylase) deficiency].
Taniguchi A
Nihon Rinsho; 2003 Jan; 61 Suppl 1():372-6. PubMed ID: 12629750
[No Abstract] [Full Text] [Related]
6. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.
Cohen A; Gudas LJ; Ammann AJ; Staal GE; Martin DW
J Clin Invest; 1978 May; 61(5):1405-9. PubMed ID: 96138
[TBL] [Abstract][Full Text] [Related]
7. [Purine nucleoside phosphorylase inhibitors and their clinical significance].
Pogosian LG; Nersesova LS; Gazariants MG; Mkrtchian ZS; Meliksetian GO; Akopian ZhI
Ukr Biokhim Zh (1999); 2008; 80(5):95-104. PubMed ID: 19248622
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency.
Fairbanks LD; Taddeo A; Duley JA; Simmonds HA
J Immunol; 1990 Jan; 144(2):485-91. PubMed ID: 2104895
[TBL] [Abstract][Full Text] [Related]
9. Evidence for purine nucleoside phosphorylase (PNP) release from rat C6 glioma cells.
Giuliani P; Zuccarini M; Buccella S; Peña-Altamira LE; Polazzi E; Virgili M; Monti B; Poli A; Rathbone MP; Di Iorio P; Ciccarelli R; Caciagli F
J Neurochem; 2017 Apr; 141(2):208-221. PubMed ID: 28251649
[TBL] [Abstract][Full Text] [Related]
10. Liquid-chromatographic study of purine metabolism abnormalities in purine nucleoside phosphorylase deficiency.
Chantin C; Bonin B; Boulieu R; Bory C
Clin Chem; 1996 Feb; 42(2):326-8. PubMed ID: 8595732
[TBL] [Abstract][Full Text] [Related]
11. Purine nucleoside phosphorylase deficiency.
Markert ML
Immunodefic Rev; 1991; 3(1):45-81. PubMed ID: 1931007
[TBL] [Abstract][Full Text] [Related]
12. Guanosine triphosphate catabolism in purine nucleoside phosphorylase deficient human B lymphoblastoid cells.
Barankiewicz J; Stein LD; Cohen A
FEBS Lett; 1984 Jan; 165(2):207-10. PubMed ID: 6420188
[TBL] [Abstract][Full Text] [Related]
13. The transition state analog inhibitor of Purine Nucleoside Phosphorylase (PNP) Immucillin-H arrests bone loss in rat periodontal disease models.
Deves C; de Assunção TM; Ducati RG; Campos MM; Basso LA; Santos DS; Batista EL
Bone; 2013 Jan; 52(1):167-75. PubMed ID: 23026564
[TBL] [Abstract][Full Text] [Related]
14. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
Dong MK; Scott ME; Schrier DJ; Suto MJ; Sircar JC; Black A; Chang T; Gilbertsen RB
J Pharmacol Exp Ther; 1992 Jan; 260(1):319-26. PubMed ID: 1530976
[TBL] [Abstract][Full Text] [Related]
15. Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes.
Kicska GA; Long L; Hörig H; Fairchild C; Tyler PC; Furneaux RH; Schramm VL; Kaufman HL
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4593-8. PubMed ID: 11287638
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BCX-34: the role of GTP and dGTP.
Bantia S; Montgomery JA; Johnson HG; Walsh GM
Immunopharmacology; 1996 Oct; 35(1):53-63. PubMed ID: 8913795
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and immunological abnormalities in purine nucleoside phosphorylase deficient mice.
Arpaia E; Gu Y; Dalal I; Kelly S; Hershfield M; Roifman CM; Cohen A
Adv Exp Med Biol; 2000; 486():41-5. PubMed ID: 11783524
[No Abstract] [Full Text] [Related]
18. Mitochondrial basis for immune deficiency. Evidence from purine nucleoside phosphorylase-deficient mice.
Arpaia E; Benveniste P; Di Cristofano A; Gu Y; Dalal I; Kelly S; Hershfield M; Pandolfi PP; Roifman CM; Cohen A
J Exp Med; 2000 Jun; 191(12):2197-208. PubMed ID: 10859343
[TBL] [Abstract][Full Text] [Related]
19. Raised IMP-dehydrogenase activity in the erythrocytes of a case of purine nucleoside phosphorylase (PNP) deficiency.
Morgan G; Strobel S; Montero C; Duley JA; Davies PM; Simmonds HA
Adv Exp Med Biol; 1991; 309B():297-300. PubMed ID: 1685860
[No Abstract] [Full Text] [Related]
20. Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)--a novel potent and orally active immunosuppressive agent.
Bantia S; Miller PJ; Parker CD; Ananth SL; Horn LL; Kilpatrick JM; Morris PE; Hutchison TL; Montgomery JA; Sandhu JS
Int Immunopharmacol; 2001 Jun; 1(6):1199-210. PubMed ID: 11407314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
